Terms: = Germ cell tumor AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580 AND Treatment
13 results:
1. AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion.
Schuster A; Klein E; Neirinckx V; Knudsen AM; Fabian C; Hau AC; Dieterle M; Oudin A; Nazarov PV; Golebiewska A; Muller A; Perez-Hernandez D; Rodius S; Dittmar G; Bjerkvig R; Herold-Mende C; Klink B; Kristensen BW; Niclou SP
Nat Commun; 2020 Dec; 11(1):6366. PubMed ID: 33311477
[TBL] [Abstract] [Full Text] [Related]
2. a20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanoma.
Guo W; Ma J; Guo S; Wang H; Wang S; Shi Q; Liu L; Zhao T; Yang F; Chen S; Chen J; Zhao J; Yu C; Yi X; Yang Y; Ma J; Ni Q; Zhu G; Gao T; Li C
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33298620
[TBL] [Abstract] [Full Text] [Related]
3. a20 promotes melanoma progression via the activation of Akt pathway.
Ma J; Wang H; Guo S; Yi X; Zhao T; Liu Y; Shi Q; Gao T; Li C; Guo W
Cell Death Dis; 2020 Sep; 11(9):794. PubMed ID: 32968045
[TBL] [Abstract] [Full Text] [Related]
4. TNIP1-mediated TNF-α/NF-κB signalling cascade sustains glioma cell proliferation.
Lei Q; Gu H; Li L; Wu T; Xie W; Li M; Zhao N
J Cell Mol Med; 2020 Jan; 24(1):530-538. PubMed ID: 31691497
[TBL] [Abstract] [Full Text] [Related]
5. Local Delivery of OncoVEX
Moesta AK; Cooke K; Piasecki J; Mitchell P; Rottman JB; Fitzgerald K; Zhan J; Yang B; Le T; Belmontes B; Ikotun OF; Merriam K; Glaus C; Ganley K; Cordover DH; Boden AM; Ponce R; Beers C; Beltran PJ
Clin Cancer Res; 2017 Oct; 23(20):6190-6202. PubMed ID: 28706012
[No Abstract] [Full Text] [Related]
6. Inhibition of a20 expression in tumor microenvironment exerts anti-tumor effect through inducing myeloid-derived suppressor cells apoptosis.
Shao B; Wei X; Luo M; Yu J; Tong A; Ma X; Ye T; Deng H; Sang Y; Liang X; Ma Y; Wu Q; Du W; Du J; Gao X; Wen Y; Fu P; Shi H; Luo S; Wei Y
Sci Rep; 2015 Nov; 5():16437. PubMed ID: 26561336
[TBL] [Abstract] [Full Text] [Related]
7. Differential effects of antofine N-oxide on solid tumor and leukemia cells.
Bour T; Yang X; Li W; Bernardin F; Kaoma T; Muller A; Vallar L; Steinmetz A
Anticancer Agents Med Chem; 2014; 14(10):1315-23. PubMed ID: 24962072
[TBL] [Abstract] [Full Text] [Related]
8. miR-125b controls apoptosis and temozolomide resistance by targeting tnfaip3 and NKIRAS2 in glioblastomas.
Haemmig S; Baumgartner U; Glück A; Zbinden S; Tschan MP; Kappeler A; Mariani L; Vajtai I; Vassella E
Cell Death Dis; 2014 Jun; 5(6):e1279. PubMed ID: 24901050
[TBL] [Abstract] [Full Text] [Related]
9. The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer.
Hemmerle T; Neri D
Int J Cancer; 2014 Jan; 134(2):467-77. PubMed ID: 23818211
[TBL] [Abstract] [Full Text] [Related]
10. a20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma.
Bellail AC; Olson JJ; Yang X; Chen ZJ; Hao C
Cancer Discov; 2012 Feb; 2(2):140-55. PubMed ID: 22585859
[TBL] [Abstract] [Full Text] [Related]
11. Immunotherapy targeting glioma stem cells--insights and perspectives.
Li Z; Lee JW; Mukherjee D; Ji J; Jeswani SP; Black KL; Yu JS
Expert Opin Biol Ther; 2012 Feb; 12(2):165-78. PubMed ID: 22200324
[TBL] [Abstract] [Full Text] [Related]
12. tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas.
Bredel M; Bredel C; Juric D; Duran GE; Yu RX; Harsh GR; Vogel H; Recht LD; Scheck AC; Sikic BI
J Clin Oncol; 2006 Jan; 24(2):274-87. PubMed ID: 16365179
[TBL] [Abstract] [Full Text] [Related]
13. PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism.
Adams S; Miller GT; Jesson MI; Watanabe T; Jones B; Wallner BP
Cancer Res; 2004 Aug; 64(15):5471-80. PubMed ID: 15289357
[TBL] [Abstract] [Full Text] [Related]
